Docoh
Loading...

BXRX Baudax Bio

APP
Utility
Nanoparticulate Meloxicam Formulations
22 Apr 21
The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
Eugene R. COOPER, Tuula RYDE, John PRUITT, Laura KLINE
Filed: 5 Jun 20
APP
Utility
CorrectedMethods of Administering Intravenous Meloxicam In a Bolus Dose
8 Apr 21
The present disclosure relates to meloxicam bolus formulations and methods of administering the same intravenously, for treatment of pain, which can provide fast onset of pain relief suitable for management of acute moderate to severe pain.
Randall J. Mack, Alex Freyer
Filed: 8 Mar 19
GRANT
Utility
Method of treating pain in elderly patients with mild renal impairment
4 Jan 21
The present disclosure relates to administration of meloxicam intravenously, for treatment of pain, in patients who are at least 65 years old and have mild renal impairment, which can provide fast onset of pain relief suitable for management of acute pain as well as moderate to severe pain.
Randall J. Mack, Stewart McCallum, Alexis Gomez, Alex Freyer
Filed: 7 Mar 19
GRANT
Utility
Nanoparticulate meloxicam formulations
13 Jul 20
The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
Filed: 24 Aug 19
GRANT
Utility
Intranasal dexmedetomidine compositions and methods of use thereof
15 Jun 20
The present invention provides intranasal formulations comprising dexmedetomidine, or a pharmaceutically acceptable salt thereof, and uses thereof.
Geraldine A. Henwood, Randall J. Mack, John Joseph Koleng, Jr., Christopher T. Sharr, Charles A. Freyer
Filed: 11 Sep 17
  • 1
Patents are sorted by USPTO publication date, most recent first